Skip to main content
. 2020 Aug 17;70(2):453–461. doi: 10.1007/s00262-020-02648-y

Fig. 4.

Fig. 4

Distribution of PD-L1+ CSCs and CD4+ T cells in NSCLC patients depending on the best overall response. a Frequency of PD-L1+ CSCs differs in patients with PD vs. SD vs. PR. *p = 0.0014 95% CI for difference: (2.85%, 7.82%) vs. (1.13%, 7.11%) vs. (0.39%, 1.90%). b Frequency of CD4 T cells in patients with PD vs. SD vs. PR. *p = 0.0453 95% CI for difference: (38.38%, 56.31%) vs. (48.45%, 64.2%) vs. (52.55%, 69.14%). c Frequency of PD-1+ CD4+ T cells in patients with PD vs. SD vs. PR. *p = 0.0099 95% CI for difference: (48.40%, 68.74%) vs. (7.45%, 70.89%) vs. (11.98%, 44.79%). d Frequency of Tim-3+ CD4+ T cells in patients with PD vs. SD vs. PR. *p = 0.0125 95% CI for difference: (11.65%, 26.38%) vs. (2.81%, 10.59%) vs. (0.77%, 13.89%)